Login

ALBANY MOLECULAR RESEARCH INC 4 SEC Filings

Filed On Filing
05 Sep 2017 Form 4: Fine Margalit, Executive Vice President, API

Received 12,318 shares as a grant or award · Returned 23,543 shares to the issuer ($512K) · Disposed of 21,725 Option to Purchase Common Stock (Disposition to Issuer) ($72.6K)

05 Sep 2017 Form 4: Ladin Felicia I, SVP, Treasurer & CFO

Received 4,993 shares as a grant or award · Returned 63,568 shares to the issuer ($1.38M) · Disposed of 172,478 Option to Purchase Common Stock (Disposition to Issuer) ($814K)

05 Sep 2017 Form 4: Hagen Steven R, SVP Manufacturing & Pharmaceut

Received 3,138 shares as a grant or award · Returned 43,655 shares to the issuer ($949K) · Disposed of 107,331 Option to Purchase Common Stock (Disposition to Issuer) ($845K)

05 Sep 2017 Form 4: Oconnor Kevin, Director

Returned 58,275 shares to the issuer ($1.27M) · Disposed of 92,347 Option to Purchase Common Stock (Disposition to Issuer) ($1.12M)

05 Sep 2017 Form 4: Napolitano Fernando, Director

Returned 3,802 shares to the issuer ($82.7K) · Disposed of 9,358 Option to Purchase Common Stock (Disposition to Issuer) ($31.3K)

05 Sep 2017 Form 4: Deming David H, Director

Returned 6,838 shares to the issuer ($149K) · Disposed of 9,358 Option to Purchase Common Stock (Disposition to Issuer) ($31.3K)

05 Sep 2017 Form 4: Gutierrez Fuentes Luis Gerardo, Director

Returned 2,206,656 shares to the issuer ($48M) · Disposed of 15,898 Option to Purchase Common Stock (Disposition to Issuer) ($70.4K)

05 Sep 2017 Form 4: Hagen Kenneth Paul, Director

Returned 6,838 shares to the issuer ($149K) · Disposed of 9,358 Option to Purchase Common Stock (Disposition to Issuer) ($31.3K)

05 Sep 2017 Form 4: Maddaluna Anthony J, Director

Returned 11,210 shares to the issuer ($244K) · Disposed of 15,898 Option to Purchase Common Stock (Disposition to Issuer) ($70.4K)

05 Sep 2017 Form 4: D Ambra Thomas E, Director

Gave 38,550 shares as a gift · Gave 46,200 shares as a gift · Returned 2,393,339 shares to the issuer ($52.1M) · 1 more

05 Sep 2017 Form 4: Conway Christopher M., SVP, Discovery and Development

Received 2,247 shares as a grant or award · Returned 47,477 shares to the issuer ($1.03M) · Disposed of 109,949 Option to Purchase Common Stock (Disposition to Issuer) ($1.15M)

05 Sep 2017 Form 4: Svokos George, Chief Operating Officer

Received 6,064 shares as a grant or award · Returned 129,150 shares to the issuer ($2.81M) · Disposed of 247,208 Option to Purchase Common Stock (Disposition to Issuer) ($2.01M)

05 Sep 2017 Form 4: Boyer Milton, SVP, Drug Product Manufacturin

Received 3,199 shares as a grant or award · Returned 42,109 shares to the issuer ($916K) · Disposed of 58,920 Option to Purchase Common Stock (Disposition to Issuer) ($257K)

05 Sep 2017 Form 4: Henderson Lori M., SVP, Secretary & Gen Counsel

Gave 9,857 shares as a gift · Received 4,722 shares as a grant or award · Returned 66,717 shares to the issuer ($1.45M) · 1 more

05 Sep 2017 Form 4: Marth William S, Director

Disposed of 38,855 shares (Other Transaction) · Returned 483,033 shares to the issuer ($10.5M) · Disposed of 188,188 Option to Purchase Common Stock (Disposition to Issuer) ($772K)

18 Jul 2017 Form 4: Fine Margalit, Executive Vice President, API

Received 5,000 shares as a grant or award · Gave up 1,500 shares to cover exercise price or tax ($32.5K)

06 Jul 2017 Form 4: Svokos George, Chief Operating Officer

Received 1,324 shares as a grant or award ($21.2K)

06 Jul 2017 Form 4: Marth William S, Director

Received 884 shares as a grant or award ($14.2K)

06 Jul 2017 Form 4: Boyer Milton, SVP, Drug Product Manufacturin

Received 1,043 shares as a grant or award ($16.7K)

05 Jul 2017 Form 4: Boyer Milton, SVP, Drug Product Manufacturin

Gave up 1,619 shares to cover exercise price or tax ($35.2K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support